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A B S T R A C T
Background
Reminder systems and late patient tracers as strategies to improve patients’ adherence to tuberculosis screening, diagnosis, and treatment
are used in some countries, but their effectiveness has not previously been systematically reviewed.
Objectives
To assess the effects of reminder systems and late patient tracers on completion of diagnostics, commencement of treatment in people
referred for curative or prophylactic treatment of tuberculosis, completion of treatment in people starting curative or prophylactic
treatment for tuberculosis, and cure in people being treated for active tuberculosis.
Search strategy
We searched the Cochrane Infectious Diseases Group Specialized Register (June 2008), Cochrane Effective Practice and Organization
of Care Group Specialized Register (April 2007), CENTRAL (The Cochrane Library 2008, Issue 2), MEDLINE (1966 to June 2008),
EMBASE (1974 to June 2008), LILACS (1982 to June 2008), CINAHL (1982 to June 2008), SCI-EXPANDED (1945 to June
2008), SSCI (1956 to June 2008), mRCT (June 2008), Indian Journal of Tuberculosis (1983 to June 2008), and reference lists. We also
contacted researchers working in the field.
Selection criteria
Randomized controlled trials (RCTs), including cluster RCTs and quasi-RCTs, and controlled before-and-after studies comparing any
reminders or late patient tracers with no or other kinds of reminders or late patient tracers. We included people in any setting who
require treatment for tuberculosis or require prophylaxis against tuberculosis and are referred to tuberculosis diagnostic or screening
services.
Data collection and analysis
Two authors independently assessed trial risk of bias and extracted data. Nometa-analysis could be undertaken due to the heterogeneity
of interventions across trials.
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Main results
Nine trials involving 5257 participants met the inclusion criteria. Three assessed the use of late patient tracers, and six assessed reminder
systems. Late patient tracers (home visit and letter) were shown to be beneficial in increasing adherence to tuberculosis treatment
compared with no late patient tracer. The results from almost all the reminder trials, except one, show benefits of different types of
reminders compared to no reminder on adherence to tuberculosis clinic appointments.
Authors’ conclusions
The included trials show significantly better outcomes among those tuberculosis patients for which late patient tracers and reminders
are used. Studies of good quality (large and with rigorous study design) are needed to decide the most effective late patient tracer actions
and reminders in different settings. Future studies of reminders in chemoprophylaxis and treatment settings would be useful.
P L A I N L A N G U A G E S U M M A R Y
Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
This review aimed to assess the effects of reminder systems and late patient tracers on patients’ adherence to medical advice (such as
attending clinic appointments for taking anti-tuberculosis drugs) and on clinical outcomes (such as cure of tuberculosis) in the following
situations: treatment for active tuberculosis; tests for diagnosis of tuberculosis; and treatment to prevent tuberculosis in high-risk
individuals. Reminder systems are used before a clinic or drug-collection appointment to remind patients to attend the appointment,
or sometimes during treatment at home to remind patients to take their drugs. Late patient tracers are similar interventions undertaken
when patients fail to keep an appointment to encourage them to return to treatment. The review found nine trials involving 5257
participants. Six trials assessed reminder systems and three trials assessed the use of late patient tracers. The results from five of the
six reminder trials showed benefits. Trials of late patient tracers (home visits and letters) also showed benefits of the intervention in
increasing adherence to tuberculosis treatment. Hence, overall, the results showed better outcomes among those patients for whom
reminders or late patient tracers were used.
B A C K G R O U N D
Prevalence of tuberculosis
Tuberculosis is a growing international health concern. As a cause
of human suffering, death, and impoverishment, tuberculosis
ranks among the leading infectious diseases. About two billion
people, or nearly one-third of the world’s population, are thought
to be infected withMycobacterium tuberculosis. There were almost
8.8 million new cases of active tuberculosis in 2005, and there
are an estimated 1.6 million deaths from tuberculosis each year (
WHO 2007).
Diagnosis and treatment
Methods of tuberculosis diagnosis vary depending on the infec-
tion, site, patient age, availability of facilities, and local policy. The
standard method of diagnosis for active pulmonary tuberculosis
is sputum microscopy, where people provide two or three sputum
samples, including an early morning sample, collected on separate
occasions. Sputum culture is also used; this detects more cases but
takes longer for the results to become available. Patients are ad-
vised to return to the clinic to receive the results, while those with
positive results are usually referred for treatment. Those with neg-
ative sputum smear results may undergo further investigation for
tuberculosis, may need to return for the results of sputum culture
tests, or both.
In some countries, groups considered to be at high risk may be
screened for tuberculosis infection (active or latent) using Puri-
fied Protein Derivative (PPD) tests (also known as tuberculin skin
test), such as Mantoux or Heaf tests, or the more recently devel-
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oped interferon-gamma blood tests. PPD tests involve injecting
a protein derivative of the M. tuberculosis bacillus into the skin,
waiting 48 to 72 hours, and then measuring any localized swelling
(or induration) of the skin around the injection site. People with
positive results may then undergo further tests to detect or ex-
clude active tuberculosis, followed by treatment for active cases
and prophylaxis for latent infection. In this review, we consider
’prophylaxis’ to mean drug prophylaxis. Prophylaxis in this case
refers to measures to prevent progression from infection to disease
through the administration of antituberculous drugs.
To be successful, the processes of screening, diagnosis, and treat-
ment require all patients to attend several healthcare appointments
(or contacts with healthcare staff ). Unless direct observation of
therapy is used, treatment for active or latent tuberculosis also re-
quires patients to take regular self-administered medication. To
cure tuberculosis with the standard regimen, the World Health
Organization (WHO) recommends that at least 75% of the pre-
scribed drugs must be taken, and, if treatment is interrupted, it
must be interrupted for less than two months (WHO 2003a).
Adherence
Adherence is defined as the extent to which a person’s behaviour
corresponds with agreed recommendations from a healthcare
provider (WHO 2003b). In the case of tuberculosis, this may be
defined as the extent to which the patient’s history of therapeu-
tic drug-taking coincides with prescribed treatment. This may be
using outcome-oriented definitions such as cure rate, or process-
related definitions such as appointment-keeping or pill counts (
WHO 2003b). More recently the term ’concordance’ has come
into use; this refers to a consensual agreement about treatment,
established between patient and practitioner. In the context of this
review, the two terms are interchangeable, as patients’ attendance
at appointments relates to both concepts (Haynes 2008).
Poor adherence to antituberculous treatment may lead to treat-
ment failure and relapse (Ormerod 1991), drug resistance (Weis
1994;Mitchison 1998), and prolonged and expensive therapy that
is less likely to be successful than the treatment of drug-susceptible
tuberculosis (Goble 1993). Poor adherence also results in increased
transmission rates of the tubercle bacilli, morbidity, and cost to
the tuberculosis control programmes (Johansson 1999).
The WHO estimates that 60% of sputum smear-positive tuber-
culosis cases were detected globally in 2005 (WHO 2007), 10%
below the 70% target. It is not known how many patients are lost
to follow up during the process of conducting various laboratory
tests (eg sputum acid-fast bacilli smears taken two to three times)
to confirm the tuberculosis diagnosis.
Globally, treatment success rates for tuberculosis since 1998 have
been close to, but persistently below, the 85% target set by the
WHO (WHO 2006). This gap is due not only to the high rates of
death among people living with HIV/AIDS but also to high rates
of treatment interruption and transfer. Also, several regions of the
world are experiencing unprecedented increases in the prevalence
of multiple-drug-resistant (MDR) tuberculosis, which threatens
tuberculosis control and translates into low cure rates. The WHO
reports that the estimated incidence in 2006 was 489,139 globally,
with the proportion of MDR tuberculosis at 4.8% (95% CI 4.6
to 6.0) (WHO 2008). There is also the severe threat of extensively
drug-resistant (XDR) tuberculosis, which has an extremely high
mortality rate.
Adherence to a tuberculosis treatment programme requires ac-
cessible and appropriate health care, and a number of interven-
tions have been used to promote adherence (WHO 2003b). This
Cochrane Review is one of several planned or in progress to eval-
uate each type of intervention:
• Reminder systems and late patient tracers in the diagnosis
and management of tuberculosis: routinely reminding patients to
keep an appointment and actions taken when patients fail to
keep an appointment (this review).
• Staff motivation and supervision: training and management
processes that aim to improve how providers care for people with
tuberculosis.
• Education and counselling for promoting adherence to the
treatment of active tuberculosis: provision of information or one-
to-one or group counselling about tuberculosis and the need to
attend for treatment (M’Imunya 2007).
• Incentives and reimbursements: money or cash in kind to
reimburse expenses of attending services, or to improve the
attractiveness of visiting the service.
• Contracts: written or verbal agreements to return for an
appointment or course of treatment (Bosch Capblanch 2007).
• Peer assistance: people from the same social group helping
someone with tuberculosis return to the health service by
prompting or accompanying them.
• Directly observed therapy (DOT): an appointed agent
(health worker, community volunteer, family member) directly
monitors people swallowing their antituberculous drugs (
Volmink 2007).
It has long been accepted that the best way to improve adherence
to long-term treatment regimens is extended supervision of and
contact with patients (Haynes 2008). This review assesses the ef-
fectiveness in improving adherence with respect to two types of
interventions to maintain contact with patients using diagnostic
and treatment services.
Reminder systems and late patient tracers
In this review, a reminder is defined as any action to contact pa-
tients shortly before they are due to take theirmedication or attend
a healthcare appointment for tuberculosis diagnosis or treatment,
and to remind them to take their medication or attend their ap-
pointment, to ensure adherence. Late patient tracers (sometimes
called ’defaulter actions’) are undertaken when patients fail to keep
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an appointment, generally to attempt tomake contact with the pa-
tient, sometimes to find out why they did not attend, and to help
patients understand the need to attend treatment and overcome
barriers to attending for treatment. The type of reminders and
late patient tracers could be visits made to patients or contacts by
health workers, letters, telephone calls (Thilakavathi 1993), and
more recently, e-mails and SMS text messages (Green 2003). Re-
minders and late patient tracers may be undertaken by health ser-
vice staff, volunteers, or community members. They might often
include a health education component, explaining to the patient
why they need to attend appointments and take their medication.
Reminders and late patient tracers are not newly developed in-
terventions, and some national treatment programmes use one
or both as standard procedure. For example, in 1988 to 1989,
the National Treatment Program Manuals in India recommended
late patient tracers to contact patients who did not return to the
clinic for their fortnightly drug collection, on the first day after a
missed appointment and then on the fourth day (Jagota 1996). In
Malaysia, where DOT is used, when patients have missed more
than seven consecutive days of treatment, a specialist late patient
tracing team visits their home to find out why they have not at-
tended the clinic for treatment. Another visit is made if the patient
subsequently fails to attend (O’Boyle 2002). Reminder systems
and late patient tracers as strategies to improve patients’ adherence
to tuberculosis screening, diagnosis, and treatment have not been
reviewed systematically before. This review seeks to fill the gap in
evidence, and highlight where more research might be needed.
O B J E C T I V E S
To assess the effects of reminder systems and late patient tracers on
completion of diagnostics, commencement of treatment in peo-
ple referred for curative or prophylactic treatment of tuberculosis,
completion of treatment in people starting curative or prophylac-
tic treatment for tuberculosis, and cure in people being treated for
active tuberculosis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Randomized controlled trials (RCTs) including cluster
RCTs and quasi-RCTs.
• Controlled before-and-after studies (CBAs).
Types of participants
• Children and adults in any setting who require treatment
for tuberculosis. This includes people with pulmonary
tuberculosis (diagnosed by sputum microscopy, culture, or both,
regardless of HIV status), smear-negative pulmonary tuberculosis
(diagnosed by symptoms and chest radiograph findings or other
diagnostic tests, regardless of HIV status), or extrapulmonary
tuberculosis (diagnosed by signs or symptoms and
histopathology, sputum acid-fast bacilli smear, culture, or both,
imaging studies or polymerase chain reaction (PCR)).
• Children and adults in any setting with tuberculosis
infection who require prophylaxis against tuberculosis.
• Children and adults in any setting referred (including self-
referred) to tuberculosis diagnostic or screening services.
Types of interventions
Interventions
• Any actions taken to remind patients to take their
tuberculosis medication or attend appointments (reminders) .
• Any actions to contact patients who have missed an
appointment (late patient tracers).
Controls
• No reminders or late patient tracers.
• Other kinds of reminder actions or other interventions to
improve adherence.
• Other kinds of late patient tracers or other interventions to
improve adherence.
Types of outcome measures
Primary
• Completion of tuberculosis diagnostics.
• Completion of screening process.
• Commencement of prophylactic treatment.
• Commencement of curative treatment.
• Completion of prophylactic treatment.
• Completion of curative treatment.
• Cure.
• Incidence of active tuberculosis (in studies of prophylactic
treatment).
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Secondary
• Any measure of adherence to treatment or attendance at
appointments.
• Any measure of patient involvement or patient satisfaction.
• Any adverse event (eg elevated liver enzymes, optic neuritis).
Search methods for identification of studies
We attempted to identify all relevant studies regardless of language
or publication status (published, unpublished, in press, and in
progress).
Databases
We searched the following databases using the search terms and
strategy described in Table 1: Cochrane Infectious Diseases Group
Specialized Register (June 2008); Cochrane Effective Practice and
Organization of Care Group Specialized Register (April 2007);
Cochrane Central Register of Controlled Trials (CENTRAL),
published in The Cochrane Library (2008, Issue 2); MEDLINE
(1966 to June 2008); EMBASE (1974 to June 2008); LILACS
(1982 to June 2008); CINAHL (1982 to June 2008); Science Ci-
tation Index Expanded (SCI-EXPANDED; 1945 to June 2008);
and the Social Sciences Citation Index (SSCI; 1956 to June 2008).
We also searched the metaRegister of Controlled Trials (mRCT)
using the terms: ’tuberculosis’ and ’(reminder OR compliance)’
(June 2008).
Table 1. Detailed search strategies
Search set Cochrane SRa CENTRAL MEDLINEb EMBASEb LILACSb SCI-EX-
PANDED &
SSCI
CINAHL
1 tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis
2 adherence PATIENT
COMPLI-
ANCE
TUBERCU-
LOSIS/
DRUG
THERAPY/
PREVEN-
TION AND
CONTROL
TUBERCU-
LOSIS
adherence adherence adherence
3 compliance PATIENT
DROPOUTS
PATIENT
COMPLI-
ANCE
PATIENT-
COMPLI-
ANCE
compliance compliance compliance
4 monitor* REMINDER
SYSTEMS
PATIENT
DROPOUTS
medication ad-
herence
monitor* monitor* monitor*
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Table 1. Detailed search strategies (Continued)
5 reminder* TREAT-
MENT
REFUSAL
COOP-
ERATIVE BE-
HAVIOUR
REMINDER-
SYSTEM
reminder* reminder* reminder*
6 2 or 3 or 4 or 5
or 6
DIRECTLY
OBSERVED
THERAPY
TREAT-
MENT
REFUSAL
TREAT-
MENT-
REFUSAL
2 or 3 or 4 or 5 non-adherence non-adherence
7 1 and 6 medication ad-
herence
medication ad-
herence
DIRECTLY-
OBSERVED-
THERAPY
1 and 6 late patient
tracer
late patient
tracer
8 - electronic
monitoring
REMINDER
SYSTEMS
electronic
monitoring
- 2-7/or 2-7/or
9 - nonadherence electronic
monitoring
nonadherence - 1 and 8 1 and 8
10 - non-adherence nonadherence non-adherence - - -
11 - late patient
tracer
non-adherence late patient
tracer
- - -
12 - 2-11/or DIRECTLY
OBSERVED
THERAPY
1 or 2 - - -
13 - 1 and 12 late patient
tracer
3-11/or - - -
14 - - 1 or 2 13 and 14 - - -
15 - - 3-13/or - - - -
16 - - 14 and 15 - - - -
aCochrane Infectious Diseases Group Specialized Register and the Cochrane Effective Practice and Organisation of Care Group
Specialized Register.
bSearch terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Lefebvre
2006); upper case: MeSH or EMTREE heading; lower case: free text term.
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Researchers and organizations
For unpublished and ongoing trials, we contacted study authors
and other researchers working in the field and the following orga-
nizations: World Health Organization (WHO); the Tuberculosis
Trials Consortium (TBTC); the International Union against TB
and Lung Diseases (IUATLD); the European Developing Coun-
tries Clinical Trials Programme (EDCTP); and the Global Part-
nership to Stop TB.
Non-indexed journals
We searched the online Indian Journal of Tuberculosis from 1983
to June 2008 using ’tuberculosis’ and ’(reminder OR compliance)’
as search terms.
Reference lists
We also checked the reference lists of all studies identified by the
above methods.
Data collection and analysis
Selection of studies
KAbba andMA Lansang independently applied the inclusion cri-
teria to all identified trials, and screened all citations and abstracts
identified by the search strategy to exclude trials that clearly did
not meet the inclusion criteria. If either of them judged that the
trial might be eligible for inclusion, we obtained the full paper. Af-
ter obtaining full reports of all potentially eligible studies, K Abba
and V Balanag assessed these for inclusion in the review using a
pre-designed eligibility form based on the inclusion criteria and
resolved any disagreements by discussion with a third author (Q
Liu). We also scrutinized publications to ensure that each trial was
included only once.
Data extraction and management
Two authors from each team (M Alejandria and R Berba for re-
minders, Q Liu and V Balanag for late patient tracers) indepen-
dently extracted the data using a tailored data extraction form.
We extracted data on study design, methods, participant charac-
teristics, interventions, and outcomes. For dichotomous data, we
extracted the number of events of interest, the total number ran-
domized to each group, and the total number analysed. For con-
tinuous data, we extracted the number of participants random-
ized, the number analysed, and the number of participants in each
group; and also the arithmetic means and their standard deviations
for some variables. Study authors were contacted to supply miss-
ing information and to clarify issues. We resolved discrepancies by
discussion.
Assessment of risk of bias in included studies
Papers selected for inclusion were divided between two teams of
review authors according to the type of intervention assessed (re-
minders or patient tracing). Two authors in each team indepen-
dently assessed the risk of bias of the included trials. M Alejandria
and R Berba for reminders; and Q Liu and V Balanag for patient
tracing.
For RCTs and quasi-RCTs, we assessed the generation of the al-
location sequence and allocation concealment as adequate, inad-
equate, or unclear according to Jüni 2001. We reported who was
blinded in each trial and classified blinding as yes, no, not possible,
and unclear for providers, participants, and assessors, respectively.
We assessed the inclusion of randomized participants in the analy-
sis as adequate if 80% or more, unclear if not described, and inad-
equate if less than 80%. We also assessed protection against con-
tamination as ’done’ if allocation was by community, institution,
or practice and it was unlikely that the control group received the
intervention, ’unclear’ if providers were allocated within a clinic
or practice and communication between experimental and group
providers was likely to occur, and ’not done’ if it was likely that
the control group received the intervention.
We used a pro-forma to guide the assessment of risk of bias. We
also contacted the study authors when essential information to
judge quality was missing. Any disagreements were resolved by
discussion and by consulting a third author (MA Lansang for
reminders and V Balanag for late patient tracers) when necessary.
Data synthesis
Q Liu undertook the analysis using Review Manager 5 in consul-
tation with the other authors. We did not pool results statistically
because of heterogeneity across the type of interventions, study
design, settings, and outcomes. We stratified the analysis by the
indication for the intervention (screening, prophylaxis, and treat-
ment), type of reminder or late patient tracer, and study design.
Risk ratios (RR) and 95% confidence intervals (CI) were used for
dichotomous data with an available-case analysis. We will use the
methods outlined in the protocol to handle other types of data (eg
continuous data or analysis of cluster trials or controlled before-
and-after studies) in future updates.
We tested for heterogeneity using the Chi2 test for heterogeneity
with a cut-off of P < 0.10 and the I2 test, with > 50% indicating
significant heterogeneity. We did not combine trials even by the
random-effectsmodel because of the significant heterogeneity. The
results were presented as forest plots without subtotals and risk
ratio calculations.Wewill use themethods outlined in the protocol
for subgroup and sensitivity analyses in future updates.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
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Nine studies involving 5257 participants met the inclusion criteria
(see ’Characteristics of included studies’). Seven were RCTs and
two were quasi-RCTs. Two were reported in one article (Roberts
1983i; Roberts 1983ii). Twelve studies that initially seemed to
fit the inclusion criteria were eventually excluded for the reasons
given in the ’Characteristics of excluded studies’.
Type of intervention
Late patient tracers
Three individually RCTs were included (Krishnaswami 1981;
Paramasivan 1993; Mohan 2003). Krishnaswami 1981 compared
the effectiveness of two kinds of late patient tracers, a home visit
and if necessary up to another three visits compared with a re-
minder letter the first time and if necessary a home visit once.
Paramasivan 1993 andMohan 2003 compared reminder letters or
routine home visiting for patients missing an appointment with a
control group without late patient tracers.
Reminder systems
Two individually quasi-RCTs (Tanke 1994; Cheng 1997) and four
individually RCTs were included (Roberts 1983i; Roberts 1983ii;
Sanmarti 1993; Tanke 1997).
Two of the trials were carried out at the same time and location,
and reported in the same article (Roberts 1983i; Roberts 1983ii),
but they were separate experiments with different participants and
interventions. Roberts 1983i compared eight groups receiving four
types of return reminders, including postcard, telephone call, di-
rect person-to-person, and take-home card in combination with
two types of authority sources (experts and non-experts). Roberts
1983ii compared 12 groups receiving a combination of two types
of message on the importance of returning (enhanced versus stan-
dard), two types of reminders (take-home card versus no reminder
card), and three types of overt commitment to return (verbal, ver-
bal plus written agreement, or no commitment).
Except for Tanke 1997, which compared a pre-recorded telephone
reminder message (TeleMinder system) twice with no reminder
message, the trials all had more than one intervention arm. Cheng
1997 applied five types of intervention for following up the tu-
berculosis test reading, of which the intervention of interest for
this review was the reminder phone call in group 2. Tanke 1994
compared no message with four types of automated telephone re-
minders (basic reminder, basic reminder plus authority endorse-
ment, basic reminder plus importance statement, and basic re-
minder plus importance statement plus authority endorsement)
for patients scheduled for three different clinic appointments.
Sanmarti 1993 compared three types of intervention with a con-
trol; the interventions in groups one and two (telephone call re-
minder and home visit by specialized nursing personnel) met our
inclusion criteria.
Countries
Of the trials assessing late patient tracers, two were carried out in
India (Krishnaswami 1981; Paramasivan 1993) and one in Iraq (
Mohan 2003). Most of the trials assessing reminders were carried
out in the USA (Roberts 1983i; Roberts 1983ii; Tanke 1994;
Cheng 1997; Tanke 1997), except one trial carried out in Spain (
Sanmarti 1993).
Participants
All three trials of late patient tracers were conducted among pa-
tients undergoing treatment for active tuberculosis. Krishnaswami
1981 included patients aged 12 years or more with radiographic
evidence of tuberculosis but negative smears, Paramasivan 1993
studied newly diagnosed adult sputum smear-positive pulmonary
tuberculosis patients, while Mohan 2003 studied new smear-pos-
itive PTB patients.
For reminders, four trials assessed the effectiveness of different
reminders on the tuberculin skin test return of different groups
of people (Roberts 1983i; Roberts 1983ii; Cheng 1997; Tanke
1997). Cheng 1997 studied children aged 1 to 12 years; Tanke
1997 studied persons of different ages (< 5 years, 5 to 12 years, 13
to 19 years, 20 to 29 years, and > 29 years); and Roberts 1983i/
Roberts 1983ii studied college students who were volunteers in a
university-sponsored tuberculosis detection drive. One of the in-
cluded trials was conducted in primary school children undergo-
ing tuberculosis chemoprophylaxis (Sanmarti 1993), and the re-
maining trial was done in a wide range of age groups receiving tu-
berculosis diagnosis, tuberculosis chemoprophylaxis, or treatment
(Tanke 1994).
Setting
All three late patient tracer trials were performed in clinics (
Krishnaswami 1981; Paramasivan 1993; Mohan 2003). The six
reminder trials were performed in different settings, including a
children’s national medical centre (Cheng 1997), clinics (Tanke
1994; Tanke 1997), a primary school (Sanmarti 1993), and a uni-
versity (Roberts 1983i; Roberts 1983ii).
Outcomes
Based on the outcomes defined in the protocol, themain outcome
assessed in the late patient tracer trials was the number of patients
who did not complete treatment. For reminders, the number of
patients who did not adhere to a scheduled appointment was the
main outcome assessed in the included trials.
Risk of bias in included studies
Our assessment of risk of bias is summarized in Table 2 with
individual trial details provided in the ’Characteristics of included
studies’.
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Table 2. Risk of bias assessment
Intervention Trial Design Generation of
allocation se-
quence
Allocation
concealment
Blinded
assessment
Inclu-
sion of ran-
domized par-
ticipants in
the analysis
Protection
against con-
tamination
Late patient
tracers
Krishnaswami
1981
RCT Unclear Unclear Unclear Adequate Unclear
Paramasivan
1993
RCT Adequate Adequate No Adequate Done
Mohan 2003 RCT Adequate Adequate Yes Adequate Done
Reminder sys-
tems
Roberts 1983i RCT Unclear Unclear Unclear Adequate Unclear
Roberts
1983ii
RCT Unclear Unclear Unclear Adequate Unclear
Sanmarti
1993
RCT Unclear Unclear Unclear Adequate Unclear
Tanke 1994 Quasi-RCT Inadequate Unclear Unclear Adequate Unclear
Cheng 1997 Quasi-RCT Inadequate Unclear Unclear Adequate Unclear
Tanke 1997 RCT Unclear Unclear Unclear Adequate Unclear
RCT: randomized controlled trial.
Late patient tracers
All three trials of late patient tracers used a RCT study design. In
both Paramasivan 1993 and Mohan 2003, the generation of the
allocation sequence and allocation concealment were adequate,
and protection against contamination was also present; while in
Krishnaswami 1981, allocation generation, allocation conceal-
ment, and protection against contamination were not clearly doc-
umented.
In all three trials, inclusion of randomized participants in the anal-
ysis was assessed as adequate, that is, over 80% of participants who
were randomized in groups were included in the analysis.
Only Mohan 2003 clearly documented blinded assessment of the
primary outcomes. Paramasivan 1993 did not blind outcome as-
sessors and Krishnaswami 1981 did not explicitly state this.
Reminders
Two trials used a quasi-RCT design (Tanke 1994; Cheng 1997),
and the remaining four trials used a RCT study design (Roberts
1983i; Roberts 1983ii; Sanmarti 1993; Tanke 1997). Cheng 1997
allocated by day of the week; for Tanke 1994, within each five-
week period eachmessage variationwas used once on eachweekday
and different variations were used each day of a given week by
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a computer-generated system. The allocation generation in four
RCTs was not clearly documented. Of all the included studies
on reminders, concealment of allocation and protection against
contamination were not clearly documented, while the inclusion
of randomized participants in the analysis was adequate. None of
the trials clearly documented blinded assessment of the primary
outcomes.
Effects of interventions
1. Late patient tracers
Three trials assessed the use of late patient tracers, and each com-
pared different types (eg letters or home visits). One trial also in-
cluded health education with the late patient tracers.
1.1. Letter versus no late patient tracer
Paramasivan 1993 compared posting of letters reminding patients
who did not collect their medication within three days of the due
date to attend and collect their medication with no late patient
tracers. Sixty pulmonary tuberculosis patients out of the 200 en-
rolled were late patients in this study. Fewer patients in the inter-
vention group (12%) did not complete treatment compared with
the control group (27%) (RR 0.44, 95% CI 0.24 to 0.83; 200
participants, Figure 1, Analysis 1.1). Eleven out of 23 patients in
the intervention group who missed their first appointment failed
to return to treatment, compared with 26 out of 29 in the control
group (RR 0.53, 95% CI 0.34 to 0.83; 52 participants, Analysis
1.2). This trial also found that treatment default, which was de-
fined by the trial as failing to collect the drugs within three days
after the due date of drug collection, was high among illiterate
patients but retrieval rate among them was also high in the inter-
vention group.
Figure 1. Late patient tracers vs no late patient tracer: Patients who did not complete treatment
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1.2. Home visit plus health education versus no late patient
tracer
Mohan 2003 studied 480 new smear-positive pulmonary tuber-
culosis (PTB) patients who delayed coming to collect drugs at the
health centre for at least three days after a scheduled appointment.
The trial compared the effectiveness of a home visit with no home
visit. The home visitors also carried out health education for the
patient and his/her family. Fewer participants (3.8%)who received
the home visit and health education failed to return for treatment
than those who did not have a home visit (17.5%) (RR 0.21, 95%
CI 0.11 to 0.43; 480 participants, Analysis 2.1). Fewer patients in
the intervention group interrupted treatment for two consecutive
months or more (RR 0.08, 95% CI 0.02 to 0.35; 480 partici-
pants, Analysis 2.2), and there were fewer treatment failures in the
home visit group (RR 0.36, 95% CI 0.13 to 0.98; 480 partici-
pants, Analysis 2.3). The number of deaths was not significantly
different between the two groups (480 participants, Analysis 2.4).
Fewer patients in the intervention group were smear positive at
two months’ follow up (RR 0.45, 95% CI 0.32 to 0.64; 480 par-
ticipants, Analysis 2.5), five months (RR 0.35, 95% CI 0.23 to
0.54; 480 participants, Analysis 2.5), and at the end of treatment
(RR 0.28, 95% CI 0.17 to 0.47; 480 participants, Analysis 2.5).
1.3. Home visit versus letter
InKrishnaswami 1981, patientswho failed to collect their drugs on
the due date received either a home visit and, if necessary, another
three visits, or a reminder letter the first time and, if necessary, one
home visit. In total, 170 patients were admitted to the study, 150
of which were included in the main analysis; of these 121 were
late patients. There was no significant difference between patients
who received home visits and those who received reminder letters
in the number of patients who did not complete treatment (150
participants, 1 trial, Figure 2, Analysis 3.1) or retrievals after the
first action for first episode of default (121 participants, 1 trial,
Analysis 3.2). However, the mean number of drug collections for
one year was reported as significantly higher in the home visit
group than in the reminder letter group (9.8 versus 8.6, P = 0.03).
We were not able to calculate the mean difference and confidence
interval as standard deviations were not provided.
Figure 2. Late patient tracers (home visit) vs letter: Patients who did not complete treatment
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Two participants withdrew from the study because of adverse
effects of the medication used (thioacetazone). Both patients were
in the group receiving the less intensive follow up (letter plus one
home visit if necessary) upon missed appointments.
2. Reminders
2.1. Automated telephone reminders versus no reminder
Tanke 1997 evaluated the effectiveness of automated telephone
reminders on tuberculin skin test return in both children and
adults. The trial authors did not present the data that would enable
us to calculate risk ratios and confidence intervals (requested data
from trial authors and awaiting reply). However, they reported
a significantly positive effect of automated telephone reminders
(7% failed to return) on return for skin test reading compared to
no reminder message (12% failed to return), with an odds ratio of
1.71 (P < 0.05).
Tanke 1994 compared four different automated telephone re-
minders in patients attending three different tuberculosis clinics
with no reminders. Patients in this study were scheduled for ap-
pointments at clinics for diagnosis, prophylaxis, and treatment.
Those receiving reminders were significantly more likely than
those not receiving reminders to attend their appointments in pro-
phylaxis clinics (RR 0.72, 95% CI 0.58 to 0.89; 536 participants,
Figure 3, Analysis 4.1) and treatment clinics (RR 0.69, 95% CI
0.56 to 0.86; 597 participants, Analysis 4.1), but there was no
significant difference between the groups in diagnosis clinics (RR
0.94, 95% CI 0.79 to 1.12; 857 participants, Analysis 4.1). There
were no significant differences in the effects of different kinds of
messages (Analysis 4.1).
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Figure 3. Reminders (automated telephone message) vs no message: Non-attendance at clinic appointment
2.2. Non-automated telephone reminder versus no reminder
Cheng 1997 compared the effectiveness of a reminder phone call
to parents of children aged one to 12 years on attendance for
Mantoux test reading with no reminder. Fewer children whose
parents received the reminder call failed to return for Mantoux
test reading (RR 0.70, 95% CI 0.50 to 0.99; 246 participants,
Analysis 5.1).
2.3. Reminder plus health education versus usual care
Sanmarti 1993 evaluated a telephone call reminder and home visit
by specialized nursing personnel every three months on the ad-
herence to tuberculosis chemoprophylaxis in school children. The
data on attendance at the last visit showed that both a telephone
call reminder (RR 0.18, 95% CI 0.07 to 0.44; 157 participants)
and home visit reminder (RR 0.14, 95% CI 0.05 to 0.39; 156
participants) significantly improved the attendance at the final ap-
pointment compared with the control group; see Figure 4 and
Analysis 6.1.
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Figure 4. Reminder plus health education vs usual care: Non-adherence to final clinic appointment
Forty-three participants withdrew from treatment; the reasons
for their withdrawal and their allocation intervention group were
not clear.
2.4. Comparisons of various reminder formats
Two trials were reported in one article; bothwere experiments with
a factorial design in volunteers (mainly college students). The first
experiment assessed four methods of providing return reminders
(postcard, telephone call, direct person-to-person, or take-home
card) in combination with two types of authority sources (expert
versus non-expert) (Roberts 1983i) . The data on return showed
no significant difference in non-attendance at clinic appointments
between participants who received reminders from experts and
those who received reminders from non-experts (200 participants,
Analysis 7.1), or between reminders delivered as a take-home card,
a postcard, a telephone call, or person-to-person message (Analysis
7.1). The second experiment assessed combinations of types of pa-
tient commitment (verbal, verbal pluswritten, or no commitment)
with importance-of-returningmessage (enhanced versus standard)
as well as with two types of return reminders (take-home card
versus no reminder) (Roberts 1983ii). The return rate for partic-
ipants who received take-home card reminders was 70.9% while
the return rate for those who received no reminders was 72.0%,
which showed no difference in non-attendance to clinic appoint-
ments between reminder group and control group (553 partici-
pants, Analysis 7.2).
D I S C U S S I O N
Nine trials, reported in eight papers, were included in this review.
Three assessed the use of late patient tracers and the other six
assessed reminder systems.
For late patient tracers, two RCTs carried out in India and Iraq
compared late patient tracer actions (letters and home visits, re-
spectively) with usual care in people being treated for tuberculo-
sis. Another RCT, also carried out in India, compared letters with
home visits. The size of trials was relatively small, ranging from
around 80 to 240 participants in each group, while the risk of bias
in the trials varied; generation of allocation sequence and alloca-
tion concealment were not clear in one trial, while the other two
trials had adequate allocation sequence generation and conceal-
ment. We could not pool the study results statistically as there was
heterogeneity in the type of interventions, study design, settings,
and outcomes.
The results favoured late patient tracer actions (home visit and
letter) compared with no late patient tracer, with reported bene-
ficial effects being both statistically and clinically significant. It is
worth noting that the use of letters appeared to be effective in en-
couraging participants to return to treatment, even in those who
were illiterate. There is inadequate evidence to show differences
between different types of late patient tracers (ie home visit versus
letter).
For reminders, almost all the trials were carried out in the USA
except one trial carried out in Spain. There is currently no good
quality research evidence on reminders available from developing
countries, where the burden of tuberculosis is highest and where
the resources available to both health services and patients are dif-
ferent. Two quasi-RCTs, using day of the week as an alternative
to randomization, assessed the use of reminders. One was con-
ducted within a screening programme and reminded people to
attend for skin test readings, and the other within three different
clinics, covering diagnosis, prophylaxis, and treatment. Two RCTs
(reported in one paper) used volunteers for a university-sponsored
tuberculosis detection drive, while another two assessed the use
of reminders in people undergoing a tuberculin skin test and in
primary school children who were on tuberculosis chemoprophy-
laxis, respectively.
The size of trials assessing reminders varied widely from around
50 participants to more than 400 in each group. The risk of bias in
the trials was generally low; two were quasi-randomized while the
other four were described as randomized, but it was unclear how
the allocation sequences were generated andwhether the allocation
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concealment was adequate. None of the trials mentioned whether
they took anymeasures to prevent the control group from receiving
the interventions. We could not pool the study results statistically
because there was heterogeneity in the types of interventions, study
design, settings, and outcomes.
The results of the trials using reminders were varied. In one RCT,
within the slightly artificial context of a university-sponsored tu-
berculosis detection drive, the number of participants returning
forMantoux test reading was no different whether they were given
a take-home reminder card or not. In another experiment, carried
out at the same place and time, there was no significant difference
in return rates between reminders given as a take-home card, a
posted card, telephone reminders, or reminders given in person
before the participants left the clinic after being given the test,
although point estimates were in favour of telephone and per-
son-to-person reminders when compared with written reminders.
In two trials (one quasi-randomized) based in real clinic settings,
significantly fewer participants missed appointments for skin test
reading in the group receiving telephone reminders (including
automated telephone reminders). In the other quasi-randomized
trial, automated telephone reminders for the diagnosis clinic had
no significant effect, but significantly fewer participants from the
prophylaxis and treatment clinics who received reminders missed
their appointments. In the trial with the co-intervention of health
education, significantly fewer participants missed the clinic ap-
pointments for tuberculosis chemoprophylaxis.
It is important to note that studies that used bundled interventions
were excluded from this review (Thiam 2007). Excluding studies
that used packaged or multiple interventions implemented under
programme conditions limits the generalizability of this review.
This also highlights the difficulty of doing systematic reviews of
trials that test multiple or combined interventions to improve ad-
herence to long-term treatment regimens. Future reviews should
consider the implementation of interventions under programme
settings. Sustainability and duration of effectiveness of the inter-
ventions are other important factors to consider in assessing the ef-
fectiveness of healthcare interventions aimed at improving adher-
ence. Strategies to improve patient adherence can be divided into
patient-oriented, provider-oriented, and system interventions.
The beneficial effects shown in the trials combining late patient
tracers or reminders with additional health education suggest that
late patient tracers or reminders may be particularly effective when
used in combination with additional education or information for
patients. However, the risk of bias in the studies warrants further
studies with improved study design. In particular, more attention
should be given to the measurement of actual patient outcomes,
such as the incidence of active tuberculosis (in prophylaxis studies),
tuberculosis cure (in treatment studies), and patient satisfaction.
Almost all the trials were conducted before or during the 1990s,
when DOT, short-course (DOTS) was not yet widely practised.
Only one trial was carried out under the DOTS strategy (Mohan
2003). This trial reported a significant improvement in return
for treatment and treatment success in the intervention group
(home visit and health education for late patients) compared with
usual care, even though the rates of return (82.5%) and treatment
success (76.7%) were also quite high in the control group. This
suggests that late patient tracer actions may be effective within
a good quality DOTS strategy. More studies assessing the use of
late patient tracers and reminders under the DOTS strategy are
needed.
A Cochrane systematic review of patient reminders and recall sys-
tems for improving immunization rates likewise showed that all
types of reminders were effective (postcards, letters, telephone, or
autodialer calls), with telephone being the most effective but most
costly (Vann 2005). All trials, however, were fromdeveloped coun-
tries only. On the other hand, the Cochrane systematic review of
DOT for tuberculosis showed no significant difference between
DOT and self-administered therapy in terms of treatment cure
and completion rates (Volmink 2007).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There are different types of late patient tracer actions and re-
minders being applied to improve adherence to tuberculosis clinic
appointments. Despite the limitations of the included studies in
terms of type of intervention, methodology, settings, and out-
comes, the results show favourable and significantly better out-
comes among those patients for whom late patient tracers or re-
minders are used. Late patient tracers (home visit and letter) are po-
tentially useful in increasing adherence to tuberculosis treatment,
and hence improving outcomes for individuals and the commu-
nity. The results from almost all the reminder trials, except one,
show benefits of different types of reminders compared to no re-
minder on adherence to tuberculosis clinic appointments.
Different types of late patient tracers and reminders can be tai-
lored to suit specific provider and practice needs. Based on cur-
rent research findings, there is not enough evidence to assess the
differences between different types of late patient tracers and re-
minders. When choosing the type of late patient tracers and re-
minders, some practical issues also need to be considered, such
as staffing, transportation, health facilities, perceived accuracy of
patient telephone numbers or addresses, availability of computer
programmers, and estimated patient responses to different types
of late patient tracers and reminders. Practitioners need to con-
sider their own settings when interpreting the findings in this re-
view since these factors vary widely across nations or geographic
regions.
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Implications for research
For late patient tracers, more good quality trials are needed to
decide the most effective late patient tracer actions in different
settings. Any future trials need to record carefully the study de-
sign, setting, the details of the intervention, and also the resource
implications. More updated trials within the DOTS strategy are
needed to confirm the effectiveness of late patient tracers.
For reminders, due to the poor quality of evidence, more well-
designed trials are needed to establish whether reminders are effec-
tive in different settings, and the best way of delivering reminders,
especially in developing countries. Specifically, future trials should
describe carefully the study design, setting, and the details of the
intervention, and report primary/clinical health outcomes of the
patients. There are no RCTs of reminders carried out in chemo-
prophylaxis or treatment settings, and considering the importance
of adherence to chemoprophylaxis and treatment appointments,
such studies would be very useful.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cheng 1997
Methods Quasi-randomized controlled trial
Generation of allocation sequence: randomized by day of the week
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 627/627 (100%)
Protection against contamination: unclear
Participants Number: 627 randomized
Inclusion criteria: consecutive children ages 1 to 12 years due for a tuberculosis test in an urban children’s hospital
outpatient department; 1 child per family enrolled
Exclusion criteria: not stated
Interventions Intervention of interest
1. Reminder phone call (reminders included a written information sheet with the times to return; skin tests circled
in permanent marker and date of return stamped on mother’s and child’s hands)
Other interventions
2. Positive reinforcement group (transportation tokens and toy on return)
3. Negative reinforcement group (asked to leave school forms until they returned for test reading and were told that
the test would be repeated if not read on time)
4. Parents trained to read the Mantoux tuberculosis test for induration or no induration, and a nurse home visit was
scheduled to verify results
Control
5. Routine verbal and written instructions
All families received education regarding the importance of skin testing for tuberculosis and the need for follow up
to read the results. Instructions were given to return to the clinic in 48 to 72 hours
Outcomes Non-adherence to return visit for Mantoux test reading
Notes Location: USA
Baseline data: comparable
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Krishnaswami 1981
Methods Randomized controlled trial
Generation of allocation sequence: unclear
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 150/170 (89%); 20 participants excluded from main analysis
because of death (8), lost to follow up (6), chemotherapy change (3), or transfer to more accessible clinics (3)
Protection against contamination: unclear
Participants Number: 170 randomized; 150 analysed
Inclusion criteria: patients with symptoms reporting at the Institute of Tuberculosis and Chest Diseases in Madras;
with radiographic evidence of tuberculosis but negative smears; aged ≥12 years; prescribed national tuberculosis
programme recommended regimen; living within a radius of about 5 km from the clinic; bona fide residents of
Madras city and regarded as stable (expected to remain in the city for at least 1 year)
Exclusion criteria: not stated
Interventions Intervention
1. In the event of default, a health visitor went to the participant’s home on the 4th day to persuade the patient to
attend the clinic. If necessary, further visits were made on the 11th day, and at 1 and 2 months. At one of the latter
2 visits, a doctor accompanied the health visitor if the latter had met the patient at an early visit but had failed to
persuade the patient to attend
Control
2. In the event of default, a reminder letter in Tamil (the local language) asking the patient to attend the clinic was
posted to the home address on the evening of the 4th day. If the patient still failed to attend, a health visitor went to
the home on the 11th day to see the patient personally and persuade him/her to attend
Outcomes 1. Failure to retrieve the defaulters with the first action for the first episode of default
2. Failure to retrieve the defaulters with the first action for all episodes of default
3. Mean number of drug collections for one year
4. Patients who discontinued treatment prematurely
5. Number of episodes of default
Notes Location: South India
Baseline data: comparable
Default: defined by the trial authors as failure of the patient to collect his/her supply of drugs on the due date or
within the next 3 days
Mohan 2003
Methods Randomized controlled trial
Generation of allocation sequence: random-numbers table
Allocation concealment: sequentially numbered and sealed opaque envelopes
Blinding of outcome assessors: yes
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 480/480 (100%)
Protection against contamination: done
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Mohan 2003 (Continued)
Participants Number: 480 randomized
Inclusion criteria: new smear-positive pulmonary tuberculosis (PTB); never been treated previously; delayed coming
to collect drugs at the health centre for at least 3 days after scheduled appointment; identified from official patient
record cards
Exclusion criteria: re-treatment patients
Interventions Intervention
1. Home visit by a local female volunteer from a local nongovernmental organization who was trained to motivate
patient to attend health centre daily and to give health education (co-intervention)for the patient and his/her family
Control
2. No home visit
Outcomes 1. Patient who did not complete treatment
2. Treatment interrupted for ≥ 2 consecutive months
3. Treatment failure: patient who is sputum positive at 5 months or later during treatment
4. Death
5. Sputum smear positive follow up
Notes Location: Iraq
Baseline data: not reported
Default: defined by the author as treatment interrupted for ≥ 2 consecutive months
Paramasivan 1993
Methods Randomized controlled trial
Generation of allocation sequence: random-numbers table
Allocation concealment: centralized randomization by a third party
Blinding of outcome assessors: no
Blinding of providers and participants: no
Inclusion of randomized participants in the analysis: 200/200 (100%)
Protection against contamination: done
Participants Number: 200 randomized
Inclusion criteria: newly diagnosed adult pulmonary tuberculosis patients; sputum positive for acid-fast bacilli (AFB);
no treatment or < 15 days previous treatment; not in moribund condition or suffering from disorders like diabetes,
cardiac failure, or renal failure; willing to stay in the hospital for the initial 1-month intensive phase of treatment
Exclusion criteria: not stated
Interventions Intervention
1. First indirect defaulter action was posting of a reminder letter to the correct home address on the 4th day of the
due date. The second defaulter action became due only when the first action failed to retrieve the patient, and it
would be posted on the 8th day after the first action.
Control
2. No reminder letter
Outcomes 1. Number of patients who did not complete treatment
2. Number of patients who did not complete the treatment in spite of defaulter retrieval
3. Defaulters retrieval
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Paramasivan 1993 (Continued)
Notes Location: South India
Baseline data: not reported
Defaulter defined by author as a patient who failed to collect the drugs within 3 days after the due date of drug
collection
Roberts 1983i
Methods Randomized controlled trial
Generation of allocation sequence: unclear
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of all randomized participants in the analysis: 200/200 (100%)
Protection against contamination: unclear
Participants Number: 200 randomized
Inclusion criteria: volunteers who participated in a university-sponsored tuberculosis detection drive; mostly college
students
Exclusion criteria: not stated
Interventions Intervention
1. Take-home card
2. Postcard
3. Telephone call
Control
Direct person-to-person reminder
Outcomes Number of participants who fail to return for skin-test reading
Notes Location: USA
Baseline data: comparable
Roberts 1983ii
Methods Randomized controlled trial
Generation of allocation sequence: unclear
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of all randomized participants in the analysis: 553/553 (100%)
Contamination: unclear
Participants Number: 553 randomized
Inclusion criteria: volunteers who participated in a university-sponsored tuberculosis detection drive
Exclusion criteria: not stated
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Roberts 1983ii (Continued)
Interventions Intervention
1. Take-home card with or without enhanced message on the importance of returning, and with or without three
types of overt commitment to return
Control
2. No reminder card
Outcomes Number of participants who fail to return for skin-test reading
Notes Location: USA
Baseline data: comparable
Sanmarti 1993
Methods Randomized controlled trial
Generation of allocation sequence: unclear
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 275/318 (85%); 43/318 (13.5%) withdrew from treatment
Protection against contamination: unclear
Participants Number: 318 randomized
Inclusion criteria: school children of both sexes in the first year of primary school in state-run and private schools in
the provinces of Barcelona, on anti-tuberculosis chemoprophylaxis
Exclusion criteria: children with active tuberculosis confirmed by medical examination and chest x-ray
Interventions Intervention of interest
1. Childrens’ mothers were telephoned by a specialized nursing personnel every 3 months who informed them of
the advantages of chemoprophylaxis for their child’s health and encouraged them to continue with this preventive
measure
Other interventions
2. Specialized nurse went to the patient’s home every 3 months providing health education to the mother and child,
encouraging them to continue with the preventive therapy, and giving them the same information leaflets given at
the first visit
3. Child was seen by the physician every 3 months at the TB Prevention and Control Centre, providing health
education and leaflets at each visit
Control
4. No health education activity performed
Outcomes 1. Non-adherence to final appointment
2. Negative Eidus-Hamilton reaction
Notes Location: Spain
Baseline data: not reported
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Tanke 1994
Methods Quasi-randomized controlled trial
Generation of allocation sequence: within each 5-week period each message variation was used once on each weekday,
different variations were used each day of a given week by a computer-generated system
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 2008/2008 (100%)
Protection against contamination: unclear
Participants Number: 2008 randomized
Inclusion criteria: patients with scheduled appointments in the Tuberculosis Control Program of Santa Clara County
Health Department over a period of 6 months
Exclusion criteria: not stated
Interventions Interventions
1. Basic reminder: pre-recorded message (TeleMinder system) from the county health department; identified the
patient by name, indicated that the patient had an appointment the following day, and gave the address and phone
number of the clinic twice; message could be repeated by remaining on the line; message did not refer to tuberculosis
2. Basic reminder plus authority endorsement: identified the Public Health Nurse at the Health Department as the
source of the message
3. Basic reminder plus importance statement: following statement was inserted after the basic information: “Coming
to this appointment is important so that you and your family will not become seriously ill.”
4. Basic reminder plus importance statement plus authority endorsement
Control
5. No message
Appropriate recorded message was sent to patients between 1800 and 2100 the evening before the scheduled ap-
pointment. The system allows a message to be left on answering machines and to call back up to 5 times at half-hour
intervals if patients’ lines were busy or there was no answer after 8 rings. For households whose primary language was
English, Spanish, Vietnamese, or Tagalog, the message was sent in that language
Outcomes Non-attendance for a scheduled appointment: if a patient had > 1 appointment during the course of the study, only
data from the first appointment were included
Notes Location: USA
Baseline data: not reported
Tanke 1994: diagnosis arm
Methods Tanke 1994 results for patients in the Reactor Clinic for diagnosis
Participants -
Interventions -
Outcomes -
Notes -
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Tanke 1994: prophylaxis arm
Methods Tanke 1994 results for patients in the INH [isoniazid] Clinic for prophylaxis
Participants -
Interventions -
Outcomes -
Notes -
Tanke 1994: treatment arm
Methods Tanke 1994 results for patients in the Case Clinic for treatment
Participants -
Interventions -
Outcomes -
Notes -
Tanke 1997
Methods Randomized controlled trial
Generation of allocation sequence: unclear
Allocation concealment: unclear
Blinding of outcome assessors: unclear
Blinding of providers and participants: not possible
Inclusion of randomized participants in the analysis: 701/701 (100%)
Protection against contamination: unclear
Participants Number: 701 randomized
Inclusion criteria: persons undergoing tuberculin skin test at the 2 largest clinics of Santa Clara (California)County
Immunization Program
Exclusion criteria: not stated
Interventions Intervention
1. Pre-recorded telephone reminder message (TeleMinder system) between 1800 and 2100 the evening before the day
on which they were to return to have their skin test read, and the information was repeated twice in the participant’s
primary language
Control
2. No reminder message
Outcomes 1. Total return failures
1.1. 2-day delay
1.2. 3-day delay
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Tanke 1997 (Continued)
Notes Location: USA
Baseline data: Not reported
Characteristics of excluded studies [ordered by study ID]
AL-Hajjaj 2000 Case-control study design
Alcaide Megías 1990 Intervention did not include reminders or late patient tracers
Bordley 2001 Most participants did not have need for screening, prophylaxis, or treatment for tuberculosis, and results for
the individuals in these categories were not presented separately
Gordillo 2003 Intervention did not include reminders or late patient tracers
Hovell 2003 Intervention did not include reminders or late patient tracers
Jin 1993 Intervention did not include reminders or late patient tracers
Krishna 2002 Review article
Lin 2006 Cohort study design
Morisky 1990 Intervention did not include reminders or late patient tracers, except for those routinely provided and also
applied to the control group
Morisky 2001 Intervention did not include reminders or late patient tracers
Nyamathi 2007 Process of late patient tracers not described, and themain objectivewas to assess predictors of latent tuberculosis
infection completion by using structural equation modelling among homeless adults
Thiam 2007 Reminders or late patient tracers not adequately described or systematically applied
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D A T A A N D A N A L Y S E S
Comparison 1. Late patient tracers vs no late patient tracer
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patients who did not complete
treatment
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Home visit plus health
education vs usual care (directly
observed therapy, short-course)
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Reminder letter vs usual
care
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Failure of patients to return to
treatment after first missed
appointment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Late patient tracers (home visit plus health education) vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patients who did not complete
treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Treatment interrupted for 2
consecutive months or more
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Treatment failure 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Death 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Sputum-smear positive follow up 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 2 months 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 5 months 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.3 End of treatment 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 3. Late patient tracers (home visit) vs letter
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patients who did not complete
treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Failure of patients to return
for treatment after missed
appointment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 4. Reminders (automated telephone message) vs no message
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-attendance at clinic
appointment
3 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Basic message vs no
message
3 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.2 Message + authority vs no
message
3 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.3 Message + importance
statement vs no message
3 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.4 Message + authority +
importance vs no message
3 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.5 Any type of message vs no
message
3 Risk Ratio (M-H, Random, 95% CI) Not estimable
Comparison 5. Reminders (non-automated reminder phone call) vs no reminder
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-adherence to Mantoux test
reading
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Reminder phone call vs no
call
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 6. Reminder plus health education vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-adherence to final clinic
appointment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Phone call plus health
education vs usual care
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Home visit plus health
education vs usual care
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 7. Reminder vs other types of reminders and no reminder
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Failed to return for skin test
reading
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Expert vs non-expert 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Take-home card vs
postcard
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Take-home card vs
telephone call
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Take-home card vs person-
to-person
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Postcard vs telephone call 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.6 Postcard vs person-to-
person
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.7 Telephone call vs person-
to-person
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 Failed to return for skin test
reading
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Late patient tracers vs no late patient tracer, Outcome 1 Patients who did not
complete treatment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 1 Late patient tracers vs no late patient tracer
Outcome: 1 Patients who did not complete treatment
Study or subgroup Late patient tracer Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Home visit plus health education vs usual care (directly observed therapy, short-course)
Mohan 2003 9/240 42/240 0.21 [ 0.11, 0.43 ]
2 Reminder letter vs usual care
Paramasivan 1993 12/100 27/100 0.44 [ 0.24, 0.83 ]
0.1 0.2 0.5 1 2 5 10
Favours late tracer Favours usual care
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Analysis 1.2. Comparison 1 Late patient tracers vs no late patient tracer, Outcome 2 Failure of patients to
return to treatment after first missed appointment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 1 Late patient tracers vs no late patient tracer
Outcome: 2 Failure of patients to return to treatment after first missed appointment
Study or subgroup Letter Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Paramasivan 1993 11/23 26/29 0.53 [ 0.34, 0.83 ]
0.1 0.2 0.5 1 2 5 10
Favours letter Favours usual care
Analysis 2.1. Comparison 2 Late patient tracers (home visit plus health education) vs usual care, Outcome
1 Patients who did not complete treatment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 2 Late patient tracers (home visit plus health education) vs usual care
Outcome: 1 Patients who did not complete treatment
Study or subgroup Home visit Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mohan 2003 9/240 42/240 0.21 [ 0.11, 0.43 ]
0.01 0.1 1 10 100
Favours home visit Favours usual care
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Analysis 2.2. Comparison 2 Late patient tracers (home visit plus health education) vs usual care, Outcome
2 Treatment interrupted for 2 consecutive months or more.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 2 Late patient tracers (home visit plus health education) vs usual care
Outcome: 2 Treatment interrupted for 2 consecutive months or more
Study or subgroup Home visit Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mohan 2003 2/240 24/240 0.08 [ 0.02, 0.35 ]
0.01 0.1 1 10 100
Favours home visit Favours usual care
Analysis 2.3. Comparison 2 Late patient tracers (home visit plus health education) vs usual care, Outcome
3 Treatment failure.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 2 Late patient tracers (home visit plus health education) vs usual care
Outcome: 3 Treatment failure
Study or subgroup Home visit Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mohan 2003 5/240 14/240 0.36 [ 0.13, 0.98 ]
0.01 0.1 1 10 100
Favours home visit Favours usual care
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Analysis 2.4. Comparison 2 Late patient tracers (home visit plus health education) vs usual care, Outcome
4 Death.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 2 Late patient tracers (home visit plus health education) vs usual care
Outcome: 4 Death
Study or subgroup Home visit Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mohan 2003 3/240 8/240 0.38 [ 0.10, 1.40 ]
0.01 0.1 1 10 100
Favours home visit Favours usual care
Analysis 2.5. Comparison 2 Late patient tracers (home visit plus health education) vs usual care, Outcome
5 Sputum-smear positive follow up.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 2 Late patient tracers (home visit plus health education) vs usual care
Outcome: 5 Sputum-smear positive follow up
Study or subgroup Home visit Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 2 months
Mohan 2003 36/240 80/240 0.45 [ 0.32, 0.64 ]
2 5 months
Mohan 2003 24/240 68/240 0.35 [ 0.23, 0.54 ]
3 End of treatment
Mohan 2003 17/240 60/240 0.28 [ 0.17, 0.47 ]
0.1 0.2 0.5 1 2 5 10
Favours home visit Favours usual care
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Analysis 3.1. Comparison 3 Late patient tracers (home visit) vs letter, Outcome 1 Patients who did not
complete treatment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 3 Late patient tracers (home visit) vs letter
Outcome: 1 Patients who did not complete treatment
Study or subgroup Home visit Letter Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Krishnaswami 1981 21/75 30/75 0.70 [ 0.44, 1.11 ]
0.01 0.1 1 10 100
Favours home visit Favours letter
Analysis 3.2. Comparison 3 Late patient tracers (home visit) vs letter, Outcome 2 Failure of patients to
return for treatment after missed appointment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 3 Late patient tracers (home visit) vs letter
Outcome: 2 Failure of patients to return for treatment after missed appointment
Study or subgroup Home visit Letter Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Krishnaswami 1981 17/57 24/64 0.80 [ 0.48, 1.32 ]
0.01 0.1 1 10 100
Favours home visit Favours letter
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Analysis 4.1. Comparison 4 Reminders (automated telephone message) vs no message, Outcome 1 Non-
attendance at clinic appointment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 4 Reminders (automated telephone message) vs no message
Outcome: 1 Non-attendance at clinic appointment
Study or subgroup Reminder Control Risk Ratio Risk Ratio
n/N n/N M-H,Random,95% CI M-H,Random,95% CI
1 Basic message vs no message
Tanke 1994: diagnosis arm 63/170 94/206 0.81 [ 0.63, 1.04 ]
Tanke 1994: prophylaxis arm 48/115 65/125 0.80 [ 0.61, 1.06 ]
Tanke 1994: treatment arm 38/122 62/125 0.63 [ 0.46, 0.86 ]
2 Message + authority vs no message
Tanke 1994: diagnosis arm 54/133 94/206 0.89 [ 0.69, 1.15 ]
Tanke 1994: prophylaxis arm 47/124 65/125 0.73 [ 0.55, 0.97 ]
Tanke 1994: treatment arm 41/120 62/125 0.69 [ 0.51, 0.93 ]
3 Message + importance statement vs no message
Tanke 1994: diagnosis arm 89/170 94/206 1.15 [ 0.93, 1.41 ]
Tanke 1994: prophylaxis arm 33/86 65/125 0.74 [ 0.54, 1.01 ]
Tanke 1994: treatment arm 50/135 62/125 0.75 [ 0.56, 0.99 ]
4 Message + authority + importance vs no message
Tanke 1994: diagnosis arm 74/178 94/206 0.91 [ 0.72, 1.15 ]
Tanke 1994: prophylaxis arm 26/86 65/125 0.58 [ 0.40, 0.84 ]
Tanke 1994: treatment arm 33/95 62/125 0.70 [ 0.50, 0.97 ]
5 Any type of message vs no message
Tanke 1994: diagnosis arm 280/651 94/206 0.94 [ 0.79, 1.12 ]
Tanke 1994: prophylaxis arm 154/411 65/125 0.72 [ 0.58, 0.89 ]
Tanke 1994: treatment arm 162/472 62/125 0.69 [ 0.56, 0.86 ]
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Analysis 5.1. Comparison 5 Reminders (non-automated reminder phone call) vs no reminder, Outcome 1
Non-adherence to Mantoux test reading.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 5 Reminders (non-automated reminder phone call) vs no reminder
Outcome: 1 Non-adherence to Mantoux test reading
Study or subgroup Reminder phone call Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Reminder phone call vs no call
Cheng 1997 37/125 51/121 0.70 [ 0.50, 0.99 ]
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Analysis 6.1. Comparison 6 Reminder plus health education vs usual care, Outcome 1 Non-adherence to
final clinic appointment.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 6 Reminder plus health education vs usual care
Outcome: 1 Non-adherence to final clinic appointment
Study or subgroup Reminder + education Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Phone call plus health education vs usual care
Sanmarti 1993 5/80 27/77 0.18 [ 0.07, 0.44 ]
2 Home visit plus health education vs usual care
Sanmarti 1993 4/79 27/77 0.14 [ 0.05, 0.39 ]
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Analysis 7.1. Comparison 7 Reminder vs other types of reminders and no reminder, Outcome 1 Failed to
return for skin test reading.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 7 Reminder vs other types of reminders and no reminder
Outcome: 1 Failed to return for skin test reading
Study or subgroup Reminder Other reminder Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Expert vs non-expert
Roberts 1983i 18/100 15/100 1.20 [ 0.64, 2.25 ]
2 Take-home card vs postcard
Roberts 1983i 8/45 13/69 0.94 [ 0.43, 2.09 ]
3 Take-home card vs telephone call
Roberts 1983i 8/45 5/42 1.49 [ 0.53, 4.20 ]
4 Take-home card vs person-to-person
Roberts 1983i 8/45 5/44 1.56 [ 0.55, 4.41 ]
5 Postcard vs telephone call
Roberts 1983i 13/69 5/42 1.58 [ 0.61, 4.12 ]
6 Postcard vs person-to-person
Roberts 1983i 13/69 5/44 1.66 [ 0.64, 4.33 ]
7 Telephone call vs person-to-person
Roberts 1983i 5/42 5/44 1.05 [ 0.33, 3.36 ]
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Analysis 7.2. Comparison 7 Reminder vs other types of reminders and no reminder, Outcome 2 Failed to
return for skin test reading.
Review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
Comparison: 7 Reminder vs other types of reminders and no reminder
Outcome: 2 Failed to return for skin test reading
Study or subgroup Take-home card Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Roberts 1983ii 81/278 77/275 1.04 [ 0.80, 1.35 ]
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